Hiroaki Nishimatsu

The University of Tokyo

Papers

1

Total Citations

34

H-Index

1

About

Dr. Hiroaki Nishimatsu is a leading urological surgeon and researcher whose work centers on the comparative effectiveness and safety of surgical interventions for prostate cancer, with a particular focus on the adoption of robotic technology. His most impactful contribution is a landmark 2014 population-based study that evaluated the safety and cost of robot-assisted radical prostatectomy (RARP) during its first year of national insurance coverage in Japan. By analyzing data from 7,202 patients, Dr. Nishimatsu provided critical, real-world evidence that RARP was a safe and viable alternative to traditional surgical approaches, directly informing clinical practice and health policy during a pivotal moment of technological transition. This highly cited work (34 citations) has become a foundational reference for researchers and surgeons assessing the integration of robotic surgery into national healthcare systems. Dr. Nishimatsu’s research is essential for understanding how surgical innovation is implemented and evaluated on a population scale, making him a key voice in the fields of urologic oncology and health services research.

Research Focus

Key Achievements

1
H-Index
1
Papers
34
Total Citations
34
Avg Citations/Paper
🏆 Most Cited Paper
Robot‐assisted versus other types of radical prostatectomy: Population‐based safety and cost comparison in Japan, 2012–2013
34 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: The University of Tokyo

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago